|
⚲
|
| Keyboard |
| Puissance Life Science Opportunities Fund VI
✚
|
|
|---|---|
| CIK # | 0001760460 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 4 | [0001760460] | |
| D | [0001760460] | |
| SC 13D | [0001760460] | |
| SC 13G | [0001760460] |
| Form 13D/13G Filer | Form 13D/13G Subject | Filed |
|---|---|---|
| Puissance Life Science Opportunities Fund VI | Bellerophon Therapeutics Inc | [2020-05-22] |
| Puissance Life Science Opportunities Fund VI | Scynexis Inc | [2019-03-15] |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Bellerophon Therapeutics LLC BLPH
Common Stock
|
2023-10-13 | Sell | 1,076,841 | $0.10 | 107,684 |
|
Bellerophon Therapeutics LLC BLPH
Common Stock
|
2023-06-07 | Sell | 134,421 | $0.83 | 111,569 |
|
Bellerophon Therapeutics LLC BLPH
Common Stock
|
2023-05-18 | Sell | 560,000 | $9.46 | 5,297,600 |
|
Bellerophon Therapeutics LLC BLPH
Common Stock
|
2021-06-07 | Grant | 8,189 | $4.00 | 32,756 |
|
Bellerophon Therapeutics LLC BLPH
Warrants (Right to buy) · derivative
|
2021-04-26 | Grant | 304,286 | $0.00 | |
|
Bellerophon Therapeutics LLC BLPH
Common Stock
|
2021-04-26 | Grant | 609,231 | $4.00 | 2,436,924 |
|
Bellerophon Therapeutics LLC BLPH
Warrants (Right to buy) · derivative
|
2021-04-26 | Grant | 380,950 | $0.00 | |
|
Bellerophon Therapeutics LLC BLPH
Common Stock
|
2020-05-21 | Grant | 1,153,846 | $13.00 | 14,999,998 |
|
Tracon Pharmaceuticals Inc TCON
Common Stock
|
2018-11-29 | Sell | 4,326 | $1.21 | 5,234 |
|
Tracon Pharmaceuticals Inc TCON
Common Stock
|
2018-11-29 | Buy | 4,326 | $1.13 | 4,888 |